Micromachines (Mar 2024)

Worm-Based Diagnosis Combining Microfluidics toward Early Cancer Screening

  • Yutao Shi,
  • Chen Cui,
  • Shengzhi Chen,
  • Siyu Chen,
  • Yiheng Wang,
  • Qingyang Xu,
  • Lan Yang,
  • Jiayi Ye,
  • Zhi Hong,
  • Huan Hu

DOI
https://doi.org/10.3390/mi15040484
Journal volume & issue
Vol. 15, no. 4
p. 484

Abstract

Read online

Early cancer diagnosis increases therapy efficiency and saves huge medical costs. Traditional blood-based cancer markers and endoscopy procedures demonstrate limited capability in the diagnosis. Reliable, non-invasive, and cost-effective methods are in high demand across the world. Worm-based diagnosis, utilizing the chemosensory neuronal system of C. elegans, emerges as a non-invasive approach for early cancer diagnosis with high sensitivity. It facilitates effectiveness in large-scale cancer screening for the foreseeable future. Here, we review the progress of a unique route of early cancer diagnosis based on the chemosensory neuronal system of C. elegans. We first introduce the basic procedures of the chemotaxis assay of C. elegans: synchronization, behavior assay, immobilization, and counting. Then, we review the progress of each procedure and the various cancer types for which this method has achieved early diagnosis. For each procedure, we list examples of microfluidics technologies that have improved the automation, throughput, and efficiency of each step or module. Finally, we envision that microfluidics technologies combined with the chemotaxis assay of C. elegans can lead to an automated, cost-effective, non-invasive early cancer screening technology, with the development of more mature microfluidic modules as well as systematic integration of functional modules.

Keywords